This occurs in a variety of tumors including GBM, wherein PrPc is emerging as both a prognostic biomarker and active player of cancer biology by promoting CSCs’ self-renewal, stemness, proliferation, and invasiveness and resistance to radio/chemotherapy. The gene discussed is PRNP; the disease is cancer.